A study published in The New England Journal of Medicine [...]
Merck has received FDA Breakthrough Therapy designation for enpatoran, an [...]
AstraZeneca is presenting a broad package of new clinical and [...]
AstraZeneca has received a positive recommendation from the Committee for [...]
AstraZeneca has reported positive interim results from the Phase 3 [...]